Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-226085
Filing Date
2018-07-25
Accepted
2018-07-25 17:27:33
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d576002ds3.htm S-3 185803
2 EX-5.1 d576002dex51.htm EX-5.1 8362
3 EX-21.1 d576002dex211.htm EX-21.1 3973
4 EX-23.1 d576002dex231.htm EX-23.1 1818
5 GRAPHIC g576002g0725075924972.jpg GRAPHIC 5156
6 GRAPHIC g576002g0725080823339.jpg GRAPHIC 2213
  Complete submission text file 0001193125-18-226085.txt   211605
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-226341 | Film No.: 18969471
SIC: 3826 Laboratory Analytical Instruments